Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Cambridge Cancer Genomics
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated. Using simple blood draws, CCG shortens the time required to know whether treatment is…
Cambridge Cancer Genomics
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated. Using simple blood draws, CCG shortens the time required to know whether treatment is…
TL;DR
Founded: 2016
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Product focus: ctDNA blood-based tests and AI analytics for precision oncology
Acquisition: Reportedly acquired by Dante Labs (June 2021)
Total disclosed funding: USD 8,500,000 (most recent disclosed: Seed, 2018-12-31)
Company Overview
Problem Domain
Precision oncology; treatment monitoring, early relapse detection, and therapy selection using liquid biopsy
Founded
2016
Industry
Biotechnology / Precision Oncology
Funding Track Record
Most recent disclosed funding event listed as a Seed round dated 2018-12-31.
$1.3M (targeted)
Reported targeted seed round cited in 2017 coverage.
Investor Signal
“Participated in Y Combinator; Crunchbase lists multiple investors including Soma Capital and Refactor”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,600+
New This Week